These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 1437309
1. Immunocytochemical detection of megakaryocytes by endothelial markers: a comparative study. Calapso P, Vitarelli E, Crisafulli C, Tuccari G. Pathologica; 1992; 84(1090):215-23. PubMed ID: 1437309 [Abstract] [Full Text] [Related]
2. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies]. Ungari M, Pellegrini W, Borlenghi E, Marocolo D, Ubiali A, Agazzi C, Pich A, Franco V, Facchetti F. Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999 [Abstract] [Full Text] [Related]
3. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders. Ohshima K, Kikuchi M, Takeshita M. J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685 [Abstract] [Full Text] [Related]
4. von Willebrand factor is the most reliable immunohistochemical marker for megakaryocytes of myelodysplastic syndrome and chronic myeloproliferative disorders. Chuang SS, Jung YC, Li CY. Am J Clin Pathol; 2000 Apr; 113(4):506-11. PubMed ID: 10761451 [Abstract] [Full Text] [Related]
5. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy. Straetmans N, Ma DD, Nevell DF, Arthur C. Hematopathol Mol Hematol; 1996 Apr; 10(4):213-22. PubMed ID: 9042664 [Abstract] [Full Text] [Related]
6. The use of the anti-factor VIII method on trephine biopsies of the bone marrow for the identification of immature and atypical megakaryocytes in myeloproliferative diseases and allied disorders. A morphometric study. Thiele J, Krech R, Wienhold S, Simon KG, Zankovich R, Fischer R. Virchows Arch B Cell Pathol Incl Mol Pathol; 1987 Apr; 54(2):89-97. PubMed ID: 2892311 [Abstract] [Full Text] [Related]
7. Immuno-, lectin-, and enzyme-histochemical characterization of human bone marrow endothelium. Masek LC, Sweetenham JW, Whitehouse JM, Schumacher U. Exp Hematol; 1994 Nov; 22(12):1203-9. PubMed ID: 7925783 [Abstract] [Full Text] [Related]
8. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A. Pathobiology; 2007 Nov; 74(2):97-114. PubMed ID: 17587881 [Abstract] [Full Text] [Related]
9. Bone marrow biopsy of aplastic anemia, myelodysplastic syndromes and myeloproliferative disorders. Kikuchi M. Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1339-46. PubMed ID: 3247814 [No Abstract] [Full Text] [Related]
10. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. Bock O, Loch G, Schade U, von Wasielewski R, Schlué J, Kreipe H. J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648 [Abstract] [Full Text] [Related]
11. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Miettinen M, Lindenmayer AE, Chaubal A. Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718 [Abstract] [Full Text] [Related]
12. Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes. Horny HP, Sotlar K, Valent P. Leuk Res; 2007 Dec; 31(12):1609-16. PubMed ID: 17604834 [Abstract] [Full Text] [Related]
13. Immunohistochemical study of Ulex europaeus agglutinin 1 (UEA-1) binding of megakaryocytes in bone marrow biopsy specimens: demonstration of heterogeneity in staining pattern reflecting the stages of differentiation. Liu SM, Li CY. Hematopathol Mol Hematol; 1996 Dec; 10(1-2):99-109. PubMed ID: 8792151 [Abstract] [Full Text] [Related]
14. [Histopathologic diagnosis of bone marrow in leukemia and related disorders]. Kikuchi M, Ohshima K, Kobari S. Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461 [Abstract] [Full Text] [Related]
15. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. Ruck P, Xiao JC, Kaiserling E. Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428 [Abstract] [Full Text] [Related]
16. Immunohistochemistry in bone marrow diagnosis. Value of a panel of monoclonal antibodies on routinely processed bone marrow biopsies. van der Valk P, Mullink H, Huijgens PC, Tadema TM, Vos W, Meijer CJ. Am J Surg Pathol; 1989 Feb; 13(2):97-106. PubMed ID: 2464955 [Abstract] [Full Text] [Related]
17. Megakaryopoiesis in chronic myeloproliferative disorders: immunohistochemical evaluation of endoreduplicative activity by PCNA-staining reaction. Thiele J, Titius BR, Kvasnicka HM, Rechmeier W, Fischer R. Anal Cell Pathol; 1994 Jul; 7(1):63-75. PubMed ID: 7981137 [Abstract] [Full Text] [Related]
18. Bone marrow trephine findings in acute myeloid leukaemia with multilineage dysplasia. Ngo N, Lampert IA, Naresh KN. Br J Haematol; 2008 Feb; 140(3):279-86. PubMed ID: 17973948 [Abstract] [Full Text] [Related]
19. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Thiele J, Kvasnicka HM, Zerhusen G, Vardiman J, Diehl V, Luebbert M, Schmitt-Graeff A. Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958 [Abstract] [Full Text] [Related]
20. Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases. Kuzmich PV, Ecker GA, Karsh J. J Rheumatol; 1994 Sep; 21(9):1649-54. PubMed ID: 7799343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]